Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting
Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting
To evaluate the impact of painPRIMER in a prospective six-month clinical investigation
 looking at clinical outcomes, health care professional and patient satisfaction, healthcare
 resource use, productivity and direct and indirect costs. The hypothesis is that early
 identification of the presence of neuropathic pain and back pain related comorbidities, to
 direct appropriate pharmacologic and non-pharmacologic treatment, painPRIMER would improve
 patient outcomes and reduce patient cycling, inappropriate use of imaging and surgery,
 thereby reducing costs and productivity loss associated with these inefficiencies.
Inclusion Criteria:

 -  Those aged 18 years of age

 -  Presenting to a HCP with low back pain

 -  Able to speak, write, and understand both verbal and written English

 Exclusion Criteria:

 -  Conditions that may impede the patient's ability to participate in painPRIMER and
 complete the questionnaires, as per the HCP's discretion

 -  Patients presenting who have undergone surgery for back pain in the previous 12 months

 -  Patients with Medicare as their primary insurance